PS Ratio Chart

View PS Ratio for GNFTF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View PS Ratio Chart
Start Trial

Historical PS Ratio Data

View and export this data back to 2014. Start Trial.
Date Value
August 27, 2026 10.63
August 26, 2026 10.63
August 25, 2026 10.63
August 24, 2026 10.63
August 21, 2026 10.99
August 20, 2026 10.99
August 19, 2026 11.13
August 18, 2026 10.76
August 17, 2026 10.76
August 14, 2026 10.76
August 13, 2026 10.76
August 12, 2026 10.76
August 11, 2026 10.76
August 10, 2026 10.76
August 07, 2026 10.76
August 06, 2026 10.76
August 05, 2026 10.76
August 04, 2026 10.76
August 03, 2026 10.76
July 31, 2026 10.76
July 30, 2026 10.76
July 29, 2026 10.76
July 28, 2026 10.76
July 27, 2026 10.76
July 24, 2026 10.76
Date Value
July 23, 2026 10.76
July 22, 2026 10.76
July 21, 2026 10.76
July 20, 2026 7.254
July 17, 2026 7.254
July 16, 2026 7.254
July 15, 2026 7.254
July 14, 2026 7.254
July 13, 2026 7.254
July 10, 2026 7.254
July 09, 2026 7.254
July 08, 2026 7.254
July 07, 2026 7.254
July 06, 2026 7.254
July 02, 2026 7.254
July 01, 2026 7.254
June 30, 2026 7.254
June 29, 2026 7.254
June 26, 2026 7.254
June 25, 2026 7.254
June 24, 2026 7.416
June 23, 2026 7.416
June 22, 2026 6.734
June 18, 2026 6.734
June 17, 2026 6.734

Price to Sales Ratio Definition

The Price to Sales Ratio (PS Ratio) is calculated by taking the stock price / revenue per share (ttm). This metric is considered a valuation metric that confirms whether the sales of a company justifies the stock price. There isn't necesarily an optimum PS ratio, since different industries will have different ranges of PS Ratios. Because of this, PS Ratio is great to evaluate from a relative standpoint with other similar companies. PS Ratio might also be a handy metric for companies that are not profitable yet, since they might be valued moreso by their overall sales and potential of becoming profitable in the future.

Read full definition.

PS Ratio Range, Past 5 Years

View PS Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

PS Ratio Benchmarks

View PS Ratio Benchmarks
Start Trial
Nicox SA 1.24
DBV Technologies SA --
Cellectis SA 6.128
Innate Pharma SA 64.42
Inventiva SA 145.07

PS Ratio Related Metrics

PEG Ratio -0.0362
Price 15.75
Earnings Yield -12.68%
Market Cap 787.82M
PEGY Ratio -0.0362